BillStime Posted May 18 Author Posted May 18 5 minutes ago, Pokebball said: prolifephobia Hardly - I support a woman’s right to manage their own health care.
The Frankish Reich Posted May 22 Posted May 22 I understand a very strong, very powerful policy statement on Trump's proposed restrictions on contraception will be coming shortly. It is next in line after his very strong, very powerful substitute for Obamacare. 1
Doc Posted May 22 Posted May 22 18 hours ago, BillStime said: @Doc certainly didn't want to touch this one... Touch what? What is he doing to birth control? 1
Tommy Callahan Posted May 24 Posted May 24 Is mifepristone available for over-the-counter use? No. Mifepristone for medical termination of a pregnancy through ten weeks gestation is currently only available by prescription. Questions and Answers on Mifepristone for Medical Termination of Pregnancy Through Ten Weeks Gestation | FDA https://pubmed.ncbi.nlm.nih.gov/33939340/ The FDA provided 6158 pages of AERs. Duplicates, non-US, or AERs previously published (Gary, 2006) were excluded. Of the remaining, there were 3197 unique, US-only AERs of which there were 537 (16.80%) with insufficient information to determine clinical severity, leaving 2660 (83.20%) Codable US AERs. (Figure 1). Of these, 20 were Deaths, 529 were Life-threatening, 1957 were Severe, 151 were Moderate, and 3 were Mild. The deaths included: 9 (45.00%) sepsis, 4 (20.00%) drug toxicity/overdose, 1 (5.00%) ruptured ectopic pregnancy, 1 (5.00%) hemorrhage, 3 (15.00%) possible homicides, 1 (5.00%) suicide, 1 (5.00%) unknown. (Table 1). Retained products of conception and hemorrhage caused most morbidity. There were 75 ectopic pregnancies, including 26 ruptured ectopics (includes one death). There were 2243 surgeries including 2146 (95.68%) D&Cs of which only 853 (39.75%) were performed by abortion providers. Of 452 patients with ongoing pregnancies, 102 (22.57%) chose to keep their baby, 148 (32.74%) had terminations, 1 (0.22%) miscarried, and 201 (44.47%) had unknown outcomes. Hemorrhage occurred more often in those who took mifepristone and misoprostol (51.44%) than in those who took mifepristone alone (22.41%). Significant morbidity and mortality have occurred following the use of mifepristone as an abortifacient. A pre-abortion ultrasound should be required to rule out ectopic pregnancy and confirm gestational age. The FDA AER system is inadequate and significantly underestimates the adverse events from mifepristone. A mandatory registry of ongoing pregnancies is essential considering the number of ongoing pregnancies especially considering the known teratogenicity of misoprostol. The decision to prevent the FDA from enforcing REMS during the COVID-19 pandemic needs to be reversed and REMS must be strengthened.
Doc Posted May 24 Posted May 24 7 hours ago, Tommy Callahan said: Is mifepristone available for over-the-counter use? No. Mifepristone for medical termination of a pregnancy through ten weeks gestation is currently only available by prescription. Questions and Answers on Mifepristone for Medical Termination of Pregnancy Through Ten Weeks Gestation | FDA https://pubmed.ncbi.nlm.nih.gov/33939340/ The FDA provided 6158 pages of AERs. Duplicates, non-US, or AERs previously published (Gary, 2006) were excluded. Of the remaining, there were 3197 unique, US-only AERs of which there were 537 (16.80%) with insufficient information to determine clinical severity, leaving 2660 (83.20%) Codable US AERs. (Figure 1). Of these, 20 were Deaths, 529 were Life-threatening, 1957 were Severe, 151 were Moderate, and 3 were Mild. The deaths included: 9 (45.00%) sepsis, 4 (20.00%) drug toxicity/overdose, 1 (5.00%) ruptured ectopic pregnancy, 1 (5.00%) hemorrhage, 3 (15.00%) possible homicides, 1 (5.00%) suicide, 1 (5.00%) unknown. (Table 1). Retained products of conception and hemorrhage caused most morbidity. There were 75 ectopic pregnancies, including 26 ruptured ectopics (includes one death). There were 2243 surgeries including 2146 (95.68%) D&Cs of which only 853 (39.75%) were performed by abortion providers. Of 452 patients with ongoing pregnancies, 102 (22.57%) chose to keep their baby, 148 (32.74%) had terminations, 1 (0.22%) miscarried, and 201 (44.47%) had unknown outcomes. Hemorrhage occurred more often in those who took mifepristone and misoprostol (51.44%) than in those who took mifepristone alone (22.41%). Significant morbidity and mortality have occurred following the use of mifepristone as an abortifacient. A pre-abortion ultrasound should be required to rule out ectopic pregnancy and confirm gestational age. The FDA AER system is inadequate and significantly underestimates the adverse events from mifepristone. A mandatory registry of ongoing pregnancies is essential considering the number of ongoing pregnancies especially considering the known teratogenicity of misoprostol. The decision to prevent the FDA from enforcing REMS during the COVID-19 pandemic needs to be reversed and REMS must be strengthened. It's interesting that they're trying to call it "birth control," i.e. conflate it with condoms and the pill. But what else is new? 1
Tommy Callahan Posted May 25 Posted May 25 12 hours ago, Doc said: It's interesting that they're trying to call it "birth control," i.e. conflate it with condoms and the pill. But what else is new? I have absolutely no problem with it being used. It's just dangerous if not used right. And totally agree how the narrative just shifted. 1
Recommended Posts